YOUR BUSINESS AUTHORITY
Springfield, MO
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
The U.S. Food and Drug Administration’s approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly’s oral drug, orforglipron, is still under review.
Both pills are GLP-1 drugs that work like widely used injectables to mimic a natural hormone that controls appetite and feelings of fullness.
Read more from the Associated Press.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Transportation officials discuss $471M Forward 44 initiative
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.
Ozarks Farm Stop remains open after car crashes into building